Corbus Pharma (CRBP) Misses Q2 EPS by 55c

Corbus Pharma (NASDAQ: CRBP) reported Q2 EPS of ($1.81), $0.55 worse than the analyst estimate of ($1.26).

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

You May Also Be Interested In

• Dyadic International, Inc. (DYAI) Misses Q2 EPS by 2c
• CoreWeave (CRWV) Reiterated at Neutral by DA Davidson Amid Rising Cost of Capital
• Performance Food Group (PFGC) Misses Q4 EPS by 1c ; Offers Guidance